Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRMD |
---|---|---|
09:32 ET | 7141 | 10.37 |
09:33 ET | 11908 | 10.23 |
09:35 ET | 14105 | 10.24 |
09:37 ET | 1700 | 10.23 |
09:39 ET | 6865 | 10.3272 |
09:42 ET | 903 | 10.32 |
09:44 ET | 2528 | 10.33 |
09:46 ET | 922 | 10.34 |
09:48 ET | 1450 | 10.37 |
09:50 ET | 2166 | 10.3453 |
09:51 ET | 3476 | 10.27 |
09:53 ET | 600 | 10.27 |
09:55 ET | 2609 | 10.3369 |
09:57 ET | 4809 | 10.27 |
10:00 ET | 1286 | 10.2793 |
10:02 ET | 5506 | 10.1401 |
10:04 ET | 700 | 10.2 |
10:06 ET | 3700 | 10.1602 |
10:08 ET | 16228 | 10.16 |
10:09 ET | 5185 | 10.175 |
10:11 ET | 1060 | 10.195 |
10:13 ET | 1784 | 10.19 |
10:15 ET | 12926 | 10.185 |
10:18 ET | 5525 | 10.146 |
10:20 ET | 6370 | 10.16 |
10:22 ET | 100 | 10.155 |
10:24 ET | 2734 | 10.115 |
10:26 ET | 1585 | 10.16 |
10:27 ET | 2765 | 10.1 |
10:29 ET | 11885 | 10.05 |
10:31 ET | 8678 | 10.06 |
10:33 ET | 4338 | 10.0196 |
10:36 ET | 9968 | 10.1 |
10:38 ET | 1610 | 10.12 |
10:40 ET | 870 | 10.13 |
10:42 ET | 100 | 10.12 |
10:44 ET | 2214 | 10.125 |
10:45 ET | 1700 | 10.18 |
10:47 ET | 200 | 10.17 |
10:49 ET | 400 | 10.135 |
10:51 ET | 1429 | 10.12 |
10:54 ET | 10609 | 10.1128 |
10:56 ET | 3520 | 10.0801 |
10:58 ET | 180 | 10.054 |
11:02 ET | 1010 | 10.09 |
11:03 ET | 5500 | 10.1 |
11:05 ET | 5201 | 10.115 |
11:07 ET | 2200 | 10.12 |
11:09 ET | 300 | 10.12 |
11:12 ET | 100 | 10.1 |
11:16 ET | 300 | 10.105 |
11:18 ET | 100 | 10.105 |
11:20 ET | 100 | 10.08 |
11:21 ET | 100 | 10.13 |
11:23 ET | 528 | 10.11 |
11:25 ET | 835 | 10.14 |
11:27 ET | 1585 | 10.08 |
11:30 ET | 400 | 10.08 |
11:32 ET | 200 | 10.09 |
11:36 ET | 5515 | 10.03 |
11:39 ET | 700 | 10.08 |
11:41 ET | 1898 | 10.1 |
11:43 ET | 385 | 10.08 |
11:48 ET | 1783 | 10.08 |
11:50 ET | 201 | 10.12 |
11:52 ET | 333 | 10.1 |
11:54 ET | 6309 | 10.12 |
11:56 ET | 1372 | 10.1 |
11:57 ET | 1210 | 10.14 |
11:59 ET | 555 | 10.1365 |
12:01 ET | 1821 | 10.13 |
12:03 ET | 2900 | 10.11 |
12:06 ET | 15015 | 10.085 |
12:08 ET | 600 | 10.0738 |
12:10 ET | 1997 | 10.0714 |
12:12 ET | 1416 | 10.065 |
12:14 ET | 960 | 10.05 |
12:15 ET | 5500 | 10.04 |
12:17 ET | 5975 | 10.05 |
12:19 ET | 399 | 10.0271 |
12:21 ET | 4900 | 10.01 |
12:24 ET | 26370 | 9.97 |
12:26 ET | 950 | 10.01 |
12:28 ET | 125 | 9.9809 |
12:32 ET | 4503 | 9.93 |
12:33 ET | 1720 | 9.944 |
12:35 ET | 2684 | 9.97 |
12:37 ET | 15190 | 10.01 |
12:39 ET | 1135 | 10.0371 |
12:42 ET | 3700 | 10.0364 |
12:44 ET | 5773 | 10.0588 |
12:46 ET | 5727 | 10.13 |
12:48 ET | 2271 | 10.1679 |
12:50 ET | 2618 | 10.18 |
12:51 ET | 1986 | 10.1852 |
12:53 ET | 1055 | 10.2332 |
12:55 ET | 1300 | 10.26 |
12:57 ET | 500 | 10.27 |
01:00 ET | 601 | 10.28 |
01:02 ET | 10202 | 10.28 |
01:04 ET | 2510 | 10.31 |
01:06 ET | 4958 | 10.37 |
01:08 ET | 6193 | 10.27 |
01:09 ET | 220 | 10.26 |
01:13 ET | 3847 | 10.27 |
01:18 ET | 6208 | 10.25 |
01:20 ET | 900 | 10.25 |
01:22 ET | 1133 | 10.28 |
01:26 ET | 433 | 10.26 |
01:27 ET | 220 | 10.2315 |
01:29 ET | 3413 | 10.21 |
01:31 ET | 675 | 10.215 |
01:33 ET | 1100 | 10.22 |
01:36 ET | 1810 | 10.17 |
01:38 ET | 2254 | 10.16 |
01:40 ET | 800 | 10.135 |
01:42 ET | 1860 | 10.12 |
01:44 ET | 8521 | 10.08 |
01:45 ET | 9193 | 10.075 |
01:47 ET | 1533 | 10.09 |
01:49 ET | 2977 | 10.08 |
01:51 ET | 1778 | 10.13 |
01:56 ET | 100 | 10.13 |
01:58 ET | 3253 | 10.1042 |
02:00 ET | 2169 | 10.1 |
02:02 ET | 300 | 10.12 |
02:03 ET | 400 | 10.12 |
02:05 ET | 100 | 10.11 |
02:07 ET | 1418 | 10.14 |
02:09 ET | 600 | 10.165 |
02:12 ET | 4541 | 10.23 |
02:14 ET | 1350 | 10.205 |
02:16 ET | 300 | 10.19 |
02:18 ET | 302 | 10.1998 |
02:20 ET | 900 | 10.2 |
02:21 ET | 3344 | 10.18 |
02:25 ET | 184 | 10.205 |
02:27 ET | 1180 | 10.2265 |
02:30 ET | 6333 | 10.23 |
02:32 ET | 5641 | 10.24 |
02:34 ET | 1508 | 10.22 |
02:36 ET | 4274 | 10.22 |
02:38 ET | 446 | 10.215 |
02:39 ET | 200 | 10.215 |
02:41 ET | 2584 | 10.2 |
02:43 ET | 1221 | 10.175 |
02:45 ET | 2574 | 10.15 |
02:48 ET | 1703 | 10.14 |
02:50 ET | 4350 | 10.14 |
02:52 ET | 1903 | 10.1395 |
02:54 ET | 132 | 10.14 |
02:56 ET | 169 | 10.14 |
02:57 ET | 5500 | 10.13 |
02:59 ET | 6929 | 10.09 |
03:01 ET | 300 | 10.06 |
03:03 ET | 15387 | 9.98 |
03:06 ET | 1441 | 9.94 |
03:08 ET | 5477 | 9.98 |
03:10 ET | 4900 | 9.98 |
03:12 ET | 1597 | 9.948 |
03:14 ET | 100 | 9.94 |
03:15 ET | 6635 | 9.94 |
03:17 ET | 1578 | 9.98 |
03:19 ET | 1566 | 9.95 |
03:21 ET | 600 | 9.96 |
03:24 ET | 3274 | 9.975 |
03:26 ET | 2591 | 9.9968 |
03:28 ET | 6595 | 9.99 |
03:30 ET | 700 | 9.97 |
03:32 ET | 300 | 9.965 |
03:33 ET | 1804 | 9.96 |
03:35 ET | 9821 | 9.97 |
03:37 ET | 17829 | 9.99 |
03:39 ET | 205 | 9.9501 |
03:42 ET | 3108 | 9.945 |
03:44 ET | 8907 | 9.945 |
03:46 ET | 2488 | 9.945 |
03:48 ET | 5279 | 9.98 |
03:50 ET | 2360 | 9.97 |
03:51 ET | 2286 | 9.96 |
03:53 ET | 4072 | 9.97 |
03:55 ET | 2521 | 9.97 |
03:57 ET | 13219 | 9.98 |
04:00 ET | 95821 | 9.96 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CorMedix Inc | 626.8M | -12.4x | --- |
Zevra Therapeutics Inc | 487.3M | -4.9x | --- |
Elite Pharmaceuticals Inc | 659.9M | -105.4x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Eton Pharmaceuticals Inc | 277.7M | -52.6x | --- |
Incannex Healthcare Inc | 34.8M | -1.4x | --- |
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $626.8M |
---|---|
Revenue (TTM) | $12.3M |
Shares Outstanding | 60.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-0.80 |
Book Value | $1.28 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 51.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -415.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.